3Yamada G,Takatani M,Kishi F,et al. Efficacy of interferon alfatherapy in chronic hepatitis C virus RNA level. Hepatology, 1995,22 : 1351.
4Hayes CN,Kobayashi M,Akuta N. HCV substitutions and IL28B polymorphisms on outcome of peg -interferon plus ribavirin combination therapy. Gut, 2011,60( 2 ) : 261-267.
5Simmonds P,Holmes EC,Cha TA,et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol, 1993,74( 11 ):2391-2399.
6Moreno C,Deltenre P,Pawlotsky JM,et al. Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta analysis. J Hepatol,2010,52 ( 1 ):25-31.
7Mangia A,Santoro R,Andriulli A,et al. Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. N Engl J Med,2005,352(25):2609-2617.
8Davis GL,Wong JB,McHutchison JG,et al. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology,2003,38(3): 645-652.
9Wong JB, Davis GL, McHutchinson JG, et al. Clinical implications of testing viral response during ribavirin and peginterferon alfa -2b treatment for chronic hepatitis C. Hepatology, 2002,36:281A.
10Yuen MF, Lai CL. Response to combined interferon and ribavirin is better in patients infected with hepatits C virus genotype 6 than genotype 1 in HongKong.Intervirology, 2006,49( 1-2 ) : 96-98.
